Clinical Trials in Phoenix

Showing 5341-5360 of 12,606 trials

GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma

NCT05242146

The STAR CNS trial is a 3-part study, comprising a phase 1b dose escalation, dose expansion, and a phase 2, to assess the safety, tolerability, dose-limiting toxicity(ies), maximum tolerated dose, and/or optimal biological dose, determine the recommended phase 2 dose, preliminary anti-tumor activity and efficacy of the recommended phase 2 dose of GB5121.

CNS Lymphoma

GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.12 participantsStarted May 2022

Phoenix, Arizona, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States +13 more locations

COMPLETEDPhase 3< 1 mile

Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)

NCT00106691

The purpose of this study is to determine if toremifene citrate is effective and safe in the prevention of prostate cancer in men who have been diagnosed with high grade prostatic intraepithelial neoplasia (PIN).

Preneoplastic ConditionsProstatic Intraepithelial Neoplasia

GTx1,589 participantsStarted Jan 2005

Huntsville, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +135 more locations

GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma

Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)

Find Trials by Condition in Phoenix

A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer

A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration

Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer

Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400)

Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma

A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas

Ventral Hernia Study Using OviTex Reinforced Bioscaffold

A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV

Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)

Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old

Study Evaluating the Safety, Tolerability, and Efficacy of FLT3 CAR-T AMG 553 in FLT3-positive Relapsed/Refractory AML

Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies

PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US